The key list

Powered by

Leading European big biopharma companies by revenue

This month our new pharma key list brings you Europe's 10 largest big biopharma companies (large pharma and large biotech) by revenue as ranked by GlobalData's Pharmaceuticals Intelligence Centre. All numbers as of October 2019.

Company nameAnnual revenue ($million)Headquarters locationNumber of employees
F. Hoffmann-La Roche Ltd54,144Switzerland94,442
Novartis AG50,135Switzerland108,000
Bayer AG40,835Germany104,226
Sanofi39,476France116,428
GlaxoSmithKline Plc38,864UK95,490
AstraZeneca Plc22,465UK64,400
Boehringer Ingelheim International GmbH19,980Germany50,000
Novo Nordisk AS16,930Denmark42,453
Allergan Plc15,941Ireland16,900
Shire Ltd15,161Ireland23,044
Company nameAnnual revenue ($million)Headquarters location
F. Hoffmann-La Roche Ltd54,144Switzerland
Novartis AG50,135Switzerland
Bayer AG40,835Germany
Sanofi39,476France
GlaxoSmithKline Plc38,864UK
AstraZeneca Plc22,465UK
Boehringer Ingelheim International GmbH19,980Germany
Novo Nordisk AS16,930Denmark
Allergan Plc15,941Ireland
Shire Ltd15,161Ireland

Share this article

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI